Medical Device Procurement in Poland: A Supplier's Guide [2026]

Poland is the largest economy in Central and Eastern Europe, with a medical device market valued at approximately EUR 3.5–4 billion annually and a public hospital network of over 900 facilities. The country operates fully under EU regulatory frameworks, hosts one of the fastest-expanding private healthcare sectors in Europe, and benefits from significant EU structural fund investment in hospital infrastructure through 2027. For medical device suppliers seeking to expand beyond Western Europe, Poland represents a high-growth, strategically positioned market.

This guide covers the regulatory pathway, procurement system, key platforms, and practical strategies for winning Polish hospital tenders in 2026.

Regulatory authority and approval pathway

Poland operates fully under the EU Medical Device Regulation (MDR 2017/745). The national competent authority is the Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych (URPL) — the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products — which handles market surveillance, vigilance reporting, and national enforcement of EU MDR requirements.

• CE marking under EU MDR: All medical devices placed on the Polish market must carry a valid CE mark issued by an EU MDR-designated Notified Body. MDD-era certificates are no longer valid for new market placements, and Polish procurement authorities routinely reject tender submissions with legacy MDD documentation — treating the absence of a valid MDR certificate as an automatic disqualification criterion.
• EUDAMED registration: Devices must be fully registered in the European Database on Medical Devices with valid UDI (Unique Device Identification) at the device and packaging level. EUDAMED registration status is increasingly cross-referenced by Polish hospital procurement teams during technical evaluation.
• Authorised Representative: Non-EU manufacturers must appoint an EU Authorised Representative under Article 11 of EU MDR. The representative's details must appear on device labelling and in EUDAMED.
• Vigilance reporting to URPL: Serious incidents and field safety corrective actions must be reported to URPL within the timelines specified in EU MDR Articles 87–90. URPL participates in the EU-level vigilance reporting network and conducts market surveillance inspections aligned with European Commission expectations.
• National device notification: In addition to EUDAMED registration, URPL may require national notifications for specific device categories. Confirm applicable requirements with URPL or your EU Authorised Representative before market entry.

Holding valid EU MDR certification provides the regulatory foundation for Poland. The market differentiator is understanding the Polish public procurement system — particularly the NFZ financing model that shapes hospital purchasing decisions.

The NFZ healthcare financing system and its procurement implications

The Narodowy Fundusz Zdrowia (NFZ) — National Health Fund — is the central payer for publicly funded healthcare in Poland. It finances hospital services through a DRG-equivalent system: the Jednorodne Grupy Pacjentów (JGP) patient classification system, which determines reimbursement rates per hospitalisation type across all contracted public hospitals.

For medical device suppliers, the NFZ-JGP model has a direct and often underestimated impact on procurement decision-making:

• Cost envelope discipline: Hospitals purchase devices within the cost envelope set by JGP reimbursement tariffs. A device that demonstrably improves outcomes while remaining within JGP economics — or that shifts patients toward higher-tariff JGP codes — has a stronger adoption argument than one that increases episode cost without a clear reimbursement mechanism.
• Health economic data: Polish hospital procurement committees — particularly medical directors and finance departments — make adoption decisions through a JGP financial lens. Suppliers who prepare Polish health economic analyses demonstrating JGP impact differentiate themselves significantly from those presenting only technical specifications.
• NFZ outpatient reimbursement list: For devices used in outpatient or home care settings, the NFZ maintains a separate reimbursement list. Securing inclusion on the NFZ outpatient list is a prerequisite for volume adoption in ambulatory care and home healthcare channels.

Understanding NFZ tariff structures for your clinical application area is as important as understanding the regulatory pathway — particularly for capital equipment and implantable devices where hospital economics directly drive procurement committee decisions.

Key procurement platforms and channels

Polish public hospital procurement is governed by the Prawo zamówień publicznych (Public Procurement Law), substantially revised in 2021 to align closely with EU Directives 2014/24/EU and 2014/25/EU. All public contract opportunities are published through official electronic platforms:

• Platforma e-Zamówień (ezamowienia.gov.pl): Poland's centralised electronic procurement platform, mandatory for all public contracting authorities since 2021. All above-threshold public tenders — including hospital contracts for medical devices — are published here. The platform replaced the older BZP system for above-threshold procurement and serves as the primary search portal for hospital tender opportunities across Poland's 16 voivodeships.
• Biuletyn Zamówień Publicznych (bzp.uzp.gov.pl): For below-threshold contracts (below PLN 130,000 for central government entities and PLN 200,000 for other public contracting authorities), contracting authorities publish on the BZP. Many hospital tenders for lower-value consumables and supplies appear here, particularly from smaller regional and municipal hospitals.
• TED (Tenders Electronic Daily): Above EU threshold contracts (EUR 215,000 for supplies) are also published on TED. Significant hospital procurement contracts — particularly for capital equipment, imaging systems, operating theatre technology, and multi-year framework agreements — appear on TED as well as e-Zamówienia.
• Individual hospital portals: Larger university hospitals (szpitale kliniczne) and major regional specialist hospitals maintain their own procurement portals in addition to national platforms. Key academic centres include the Medical University of Warsaw, Jagiellonian University Medical College (Kraków), Medical University of Gdańsk, and Wrocław Medical University — all significant buyers of advanced medical devices.

Monitoring e-Zamówienia, BZP, TED, and individual hospital portals simultaneously across Poland's 16 voivodeships is resource-intensive without automation. MedStrato's tender monitoring consolidates Polish procurement opportunities across all primary channels into a single feed.

Procurement structure: voivodeship ownership and group purchasing

Unlike Western European markets with dominant central purchasing bodies or GPO networks, Poland's public hospital procurement is highly fragmented. Most public hospitals are owned by local government entities — voivodeships (provinces), municipalities, or in some cases the Ministry of Health — and run independent procurement processes. This creates 900+ independent procurement decision points, each requiring separate engagement.

Several centralised mechanisms partially consolidate procurement:

• Agencja Rezerw Materiałowych (ARM): The Material Reserves Agency conducts centralised procurement for strategic medical reserves and can run joint procurement for health system needs. Since the COVID-19 pandemic, ARM has taken on a broader coordination role in medical supply procurement and strategic equipment purchasing.
• Voivodeship-level coordination: Some voivodeships organise joint procurement for common consumable categories across their hospital networks. Warsaw's Mazowieckie region and Silesia (Śląsk) have the most active inter-hospital procurement coordination structures.
• Private hospital groups: Poland's expanding private healthcare sector includes Medicover (NASDAQ-listed), LuxMed (Vienna Insurance Group), Enel-Med, and Scanmed. These groups run centralised purchasing through group procurement negotiations rather than formal public tender processes, offering a distinct commercial channel alongside public procurement.

Compliance requirements for Polish hospital tenders

Polish public procurement follows the Prawo zamówień publicznych (PZP) framework. Key compliance requirements for medical device suppliers responding to Polish hospital tenders:

• Language: All tender submissions must be in Polish. Technical documentation, Instructions for Use (IFU), product labelling, and safety information must be fully translated. Hospital evaluation committees routinely disqualify non-Polish-language submissions even where the technical content would otherwise meet all qualification criteria.
• EU MDR compliance documentation: Valid CE certificate under EU MDR, EUDAMED registration confirmation, and current UDI assignment are required for all device categories. For Class III and certain Class IIb devices, SSCP (Summary of Safety and Clinical Performance) documentation is increasingly requested. See EU MDR tender requirements 2026 for a full compliance checklist.
• ISO 13485 certification: Quality management system certification is expected as a minimum qualification criterion for public hospital contracts. Certificates must be current (not within 90 days of expiry at submission) and from an accredited certification body. Some tenders additionally specify EN ISO 14971 risk management or IEC 62304 software requirements for relevant device categories.
• Financial and legal solvency documentation: Polish public procurement requires submission of financial standing documents (audited accounts, bank capacity letters) and legal compliance declarations. Foreign suppliers may use equivalent documentation from their home jurisdiction with certified Polish translation.
• JEDZ/ESPD: For above-threshold tenders, the European Single Procurement Document (JEDZ in Polish) serves as the standard preliminary self-declaration of qualification. Polish procurement authorities use the electronic JEDZ system integrated with e-Zamówienia.

Market size and opportunity

Poland's medical device market is valued at EUR 3.5–4 billion annually, with public healthcare accounting for approximately 65% of total health expenditure. Market growth has accelerated following major NFZ spending increases and EU structural fund investments in hospital infrastructure. High-opportunity segments include:

• Diagnostic imaging: Poland's public hospital imaging infrastructure requires significant modernisation. EU structural funds are financing CT, MRI, and digital radiology upgrades across regional hospitals, with procurement concentrated between 2024 and 2027 — creating an active window for imaging systems suppliers.
• Surgical systems and operating theatre technology: University hospitals and major regional centres are investing in robotic surgery platforms, laparoscopic systems, and advanced OR infrastructure. Polish surgical adoption rates are accelerating as academic centres benchmark against Western European peers.
• In-vitro diagnostics: Poland's laboratory market is one of the fastest-growing in Central Europe. Hospital laboratory consolidation creates framework contract opportunities for reagent suppliers and analyser manufacturers, particularly as voivodeships standardise laboratory equipment across their hospital networks.
• Infusion therapy and critical care: Post-pandemic hospital investment programmes have generated sustained procurement of infusion systems, patient monitoring equipment, and ICU technology across Poland's public hospital network, with refreshment cycles now accelerating into new tender rounds.
• Home healthcare and digital health: The private healthcare and digital health segment is growing at 15–20% annually. Connected monitoring devices and chronic disease management platforms are experiencing strong adoption in private clinic networks and through NFZ-funded telemedicine initiatives.

Tips for foreign suppliers entering Poland

1. Invest in Polish-language capability: Polish-language tender submissions, product documentation, and Polish-speaking sales and clinical support capability are non-negotiable for sustained hospital procurement success. Machine-translated documentation is detectable and creates credibility issues with hospital evaluation committees that weigh supplier reliability as a scoring criterion.
2. Build JGP health economic arguments: Polish hospital procurement committees make device adoption decisions through a JGP financial lens. Prepare health economic analyses that demonstrate how your device affects specific JGP codes relevant to your clinical application area. This differentiation is particularly powerful for capital equipment and implantable devices where committee approvals depend on financial return calculations.
3. Prioritise high-volume voivodeships: Mazowieckie (Warsaw), Śląskie (Silesia), and Małopolskie (Kraków) represent the largest hospital procurement volumes and typically offer the most organised procurement processes. Build direct relationships with voivodeship hospital network coordinators in these regions before expanding to the remaining 13.
4. Engage a local distribution partner: A Polish distributor or subsidiary with existing hospital relationships and a local service network significantly improves tender competitiveness. Polish hospital procurement authorities score local service capability and support response times — a local partner consistently outperforms a remote international team on these qualitative scoring criteria.
5. Monitor EU structural fund tenders: Poland is the largest recipient of EU cohesion funds in the 2021–2027 programming period, with significant healthcare infrastructure allocation. EU-funded hospital tenders often have larger values and more competitive timelines than routine consumable procurement. Book a MedStrato demo to see how EU-funded tender opportunities are tracked alongside routine Polish hospital procurement across all portals.

Common rejection reasons in Polish tenders

The most frequent technical rejection reasons for medical device suppliers in Polish hospital procurement are:

• Submitting MDD-era CE certificates or EU MDR certificates that have lapsed
• Non-Polish-language tender submission
• Missing or inconsistent EUDAMED registration data
• ISO 13485 certificates near expiry or from unaccredited certification bodies
• Insufficient Polish-language product documentation (IFU, technical datasheets)
• Missing UDI documentation at the packaging level specified in the tender requirements
• Failure to include health economic or JGP impact data when explicitly requested in tender evaluation criteria

Automated compliance verification before submission catches most regulatory document failures before they reach the hospital procurement desk. MedStrato cross-checks EU MDR certificate validity, EUDAMED registration status, and UDI compliance against each tender requirement in real time, flagging gaps before your submission deadline.

Ready to pursue Poland's hospital tender market? Book a demo to see how MedStrato handles Polish tender compliance and monitoring, or explore the full feature set for multi-market medical device tender management.